The Moroccan Medicines Agency withdraws two batches of cardioaspirin for the heart

The National Agency for Medicines and Health Products in Morocco, in coordination with the German pharmaceutical company Bayer, announced the withdrawal of two batches of cardioaspirin 100 mg from pharmacies and distribution networks in the Kingdom, as a precautionary measure after monitoring a defect in the conditions of transporting the quantities concerned. The two payments in question relate exclusively to the BT1CJP2 and BT1CJP3 payments, which have a validity date of February 2031. The concerned authorities explained that the reason for the withdrawal is due to a deviation in the circumstances of Transportation, but the decision does not include the rest of the batches of the drug in the market, which remain outside the scope of the withdrawal process and are normally available in pharmacies. Cardioaspirin: A preventive drug for cardiovascular patients Cardioaspirin 100 mg contains acetylsalicylic acid, is offered in the form of stomach-resistant tablets, and is usually prescribed within medical treatments to prevent some cardiovascular complications. It was stressed that no complaint regarding the quality of the two payments in question, nor any case of Pharmacovigilance is related to the cause of withdrawal, and that the procedure remains purely preventive. The procedures required of pharmacists and distributors Pharmacists and drug distributors were requested to immediately stop disbursing and distributing the two batches in question, place the available quantities of them under quarantine, and initiate procedures for returning them to the manufacturing laboratory. This procedure is part of the tracking mechanisms that allow monitoring any defect in the manufacture, storage or transport of pharmaceutical products traded on the national market, with the aim of ensuring the continued availability of the drug safely for cardiac patients who depend on it for their daily treatments. What does a person with this medicine do? The batch number is printed on the medicine box, and any patient in possession of a cardioaspirin 100 mg can make sure that the number on it matches the references "BT1CJP2" or "BT1CJP3", and in the event of a match, go to the pharmacy to exchange it, knowing that the rest of the payments circulating in the market are valid and are not covered by the withdrawal decision. The National Agency for Medicines and Health Products, as the body charged with monitoring the safety of medicines In Morocco, following up on such cases whenever an imbalance is observed in the manufacturing, transportation or storage chain, to ensure that non-conforming products do not reach patients.